188781-10-4 Usage
General Description
5-Pyrimidinecarboxylic acid, 2-chloro-4-methyl- (9CI) is a chemical compound with the molecular formula C6H5ClN2O2. It is a derivative of 2-chloro-4-methylpyrimidine and has a pyrimidine ring with a carboxylic acid functional group and a methyl and chlorine substituent. 5-Pyrimidinecarboxylic acid, 2-chloro-4-methyl- (9CI) is commonly used in pharmaceutical research and development due to its potential pharmacological properties. It has been studied for its potential as an anti-inflammatory and anti-cancer agent, as well as for its antimicrobial and antiviral properties. Additionally, it may also have applications in the development of agrochemicals and other specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 188781-10-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,8,7,8 and 1 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 188781-10:
(8*1)+(7*8)+(6*8)+(5*7)+(4*8)+(3*1)+(2*1)+(1*0)=184
184 % 10 = 4
So 188781-10-4 is a valid CAS Registry Number.
188781-10-4Relevant articles and documents
HETEROAROMATIC CARBOXAMIDE DERIVATIVES AS PLASMA KALLIKREIN INHIBITORS
-
Page/Page column 194, (2021/08/20)
Heteroaromatic carboxamides of formula (I), wherein Y, R, and Ar are as defined in the description and the claims, and pharmaceutically acceptable salts thereof can be used in methods for the treatment of diseases which can be influenced by the inhibition of plasma kallikrein.
Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
-
, (2008/06/13)
Compounds having utility as anti-inflammatory agents in general and, more specifically, for the prevention and/or treatment of immunoinflammatory and autoimmune diseases are disclosed. The compounds are pyrimidine-containing compounds and, in one embodiment, are esters of the same. Methods are also disclosed for preventing and/or treating inflammatory conditions by administering to an animal in need thereof an effective amount of a compound of this invention, preferably in the form of a pharmaceutical composition.